We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

182 hedge funds and large institutions have $1.34B invested in Heron Therapeutics in 2020 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 61 increasing their positions, 64 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.22% more ownership

Funds ownership: 97.77% → 99.99% (+2.2%)

1% more capital invested

Capital invested by funds: $1.33B → $1.34B (+$9.06M)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

5% less repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 64

6% less call options, than puts

Call options by funds: $1.01M | Put options by funds: $1.08M

4% less funds holding

Funds holding: 190 → 182 (-8)

28% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 29

Holders
182
Holders Change
-8
Holders Change %
-4.21%
% of All Funds
3.67%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
21
Increased
61
Reduced
64
Closed
29
Calls
$1.01M
Puts
$1.08M
Net Calls
-$65K
Net Calls Change
+$1.09M

Top Buyers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
+$31.3M
2
RCAMU
Rothschild & Co Asset Management US
Connecticut
+$17.2M
3
State Street
State Street
Massachusetts
+$8.89M
4
O
OrbiMed
New York
+$8.29M
5
Wellington Management Group
Wellington Management Group
Massachusetts
+$7.62M

Top Sellers

Rank Fund Capital Flow
1
Fidelity International
Fidelity International
Bermuda
-$14.8M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$12.4M
3
BlackRock
BlackRock
New York
-$7.66M
4
Holocene Advisors
Holocene Advisors
New York
-$5.9M
5
PHS
PFM Health Sciences
California
-$5.61M
Name Holding Trade Value Shares
Change 		Change in
Stake
Pacer Advisors
151
Pacer Advisors
Pennsylvania
$59K +$62.5K +4,006 New
SGAM
152
Smith Group Asset Management
Texas
$55K +$14.2K +910 +32%
IF
153
Ironwood Financial
Arizona
$43K – – –
PCIA
154
Prime Capital Investment Advisors
Kansas
$30K +$14.8K +950 +90%
SPIA
155
Steward Partners Investment Advisory
New York
$22K – – –
CA
156
Clearstead Advisors
Ohio
$21K – – –
S
157
SignatureFD
Georgia
$19K +$19.5K +1,250 New
WAS
158
Winch Advisory Services
Wisconsin
$15K – – –
Northwestern Mutual Wealth Management
159
Northwestern Mutual Wealth Management
Wisconsin
$15K +$15.6K +1,000 New
FDCDDQ
160
Federation des caisses Desjardins du Quebec
Quebec, Canada
$13.6K +$14.3K +915 New
CFGS
161
Concourse Financial Group Securities
Alabama
$11K +$640 +41 +6%
BCV
162
Banque Cantonale Vaudoise
Switzerland
$9K +$9.36K +600 New
Carson Wealth (CWM LLC)
163
Carson Wealth (CWM LLC)
Nebraska
$7K – – –
EWM
164
Endurance Wealth Management
Rhode Island
$6K – – –
BAM
165
Bellevue Asset Management
Washington
$4K – – –
IWP
166
IAG Wealth Partners
Wisconsin
$4K – – –
US Bancorp
167
US Bancorp
Minnesota
$4K – – –
Millennium Management
168
Millennium Management
New York
$3.03K +$3.19M +204,238 New
PA
169
Parallel Advisors
California
$3K -$1.9K -122 -38%
VFA
170
Valeo Financial Advisors
Indiana
$3K -$1.06K -68 -25%
SFS
171
Sowell Financial Services
Arkansas
$2K -$3.31K -212 -57%
CAPTRUST Financial Advisors
172
CAPTRUST Financial Advisors
North Carolina
$2K -$1.56K -100 -50%
GWS
173
Glassman Wealth Services
Virginia
$2K – – –
Rockefeller Capital Management
174
Rockefeller Capital Management
New York
$2K – – –
RE
175
RBC Europe
United Kingdom
$1.78K – – –
5 6
7
8 9

HRTX Hedge Fund Activity: Q3 2020 in Review

182 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q3 2020, worth a combined $1.34B — up 0.68% from $1.33B a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of HRTX and 21 opened new positions — a net loss of 8 holders — while 64 trimmed existing stakes and 61 added.

The largest buyer was Consonance Capital Management, opening a new position worth an estimated $31.3M. The largest seller was Fidelity International, cutting an estimated $14.8M.

  • 182 institutional investors held Heron Therapeutics (HRTX) as of Q3 2020, down from 190 in Q2 2020.
  • Funds reported $1.34B of Heron Therapeutics stock for Q3 2020, up 0.68% quarter-over-quarter.
  • 21 funds opened new Heron Therapeutics positions in Q3 2020 and 29 closed out, a net change of -8 holders.
  • The largest Heron Therapeutics buyer in Q3 2020 was Consonance Capital Management, an estimated $31.3M added.
  • The largest Heron Therapeutics seller in Q3 2020 was Fidelity International, an estimated $14.8M sold.

Based on aggregated 13F filings for Q3 2020.